Adenylate cyclase toxin-mediated delivery of the S1 subunit of pertussis toxin into mammalian cells
Author(s) -
Masaaki Iwaki,
Toshifumi Konda
Publication year - 2015
Publication title -
pathogens and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.983
H-Index - 105
ISSN - 2049-632X
DOI - 10.1093/femspd/ftv110
Subject(s) - bordetella pertussis , adenylate cyclase toxin , pertussis toxin , adp ribosylation , cyclase , toxin , protein subunit , bordetella , pertactin , adenylate kinase , endocytosis , biochemistry , diphtheria toxin , biology , g protein , effector , epitope , chemistry , microbiology and biotechnology , antigen , receptor , bacteria , enzyme , nad+ kinase , genetics , gene
The adenylate cyclase toxin (ACT) of Bordetella pertussis internalizes its catalytic domain into target cells. ACT can function as a tool for delivering foreign protein antigen moieties into immune effector cells to induce a cytotoxic T lymphocyte response. In this study, we replaced the catalytic domain of ACT with an enzymatically active protein moiety, the S1 (ADP-ribosyltransferase) subunit of pertussis toxin (PT). The S1 moiety was successfully internalized independent of endocytosis into sheep erythrocytes. The introduced polypeptide exhibited ADP-ribosyltransferase activity in CHO cells and induced clustering typical to PT. The results indicate that ACT can act as a vehicle for not only epitopes but also enzymatically active peptides to mammalian cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom